Showing: 1 - 10 of 14 RESULTS

Plenary Session 3

“Artificial Intelligence in the Pharmacological Treatment of Psychiatric Conditions” Depression is a complex and often chronic illness. Improving health outcomes in depression begins with improving characterization of the illness in those affected. Ecological momentary assessment (EMA) provides opportunity for passive and ambient collection of data that EMA devices suggest can determine whether a patient is …

Meet the Experts 3

“Building evidence for sequenced depression treatment” In 2009 we published one of the earlier network meta-analyses (NMA) of 12 new generation antidepressants in the acute phase treatment of depression 1. In 2018 we expanded and updated this NMA by including five more new generation antidepressants and four old antidepressants (522 trials, 116 477 participants) 2. …

Meet the Experts 2

“Advances in the understanding and management of treatment resistance in bipolar disorder“ “Treatment resistance” is a definition that does not belong to the classification system, because it depends on the availability of suitable therapies at a given point in history. However, it has regulatory implications, and it may be useful for clinical practice. Treatment resistance …

Plenary Session 1

“Challenges in the Treatment of Bipolar Disorders: Looking Ahead” Bipolar disorder is a complex psychiatric condition with pleomorphic presentations, varied course and high comorbidity. While several options are available for treating mania and preventing mania, many challenges remain in providing optimal outcomes for patients with bipolar disorder. For instance, treatment options continue to be limited …